A group of Big Law’s best-known M&A brands pitched in on a pair of newly announced pharmaceutical deals, the latest in what’s been a year full of major deal work for large firms working in this space.
Smaller firms appear to be punching above their weight in the M&A market, according to recent data, prompting Big Law Business to look at a trend that could flip the script on Big Law firms that …
Cleary, Gottlieb, Steen & Hamilton announced it advised Alphabet Inc.’s Google in its $2.1 billion purchase of smartwatch maker Fitbit, which tapped Fenwick & West for advice.
Wachtell Lipton Rosen & Katz is heading into the year’s final quarter outpacing all other law firms in the dollar value of global mergers and acquisitions on which it’s served as an adviser.
Kirkland & Ellis advised Bristol-Myers Squibb Co. in its all-cash $13.4 billion sale of Celgene Corp.’s psoriasis drug Otezla to Amgen Inc., which is being advised by Sullivan & Cromwell.
Munger,Tolles & Olson partner George Fatheree III recently succeeded in preserving for the public an invaluable visual archive of 20th century black America—and he and his colleagues only had 48 …
Hogan Lovells is representing Russian billionaire Mikhail Prokhorov in his sale of the Barclays Center and controlling interest in the Brooklyn Nets to an entity controlled by Joe Tsai, co-founder …
Skadden Arps, Slate, Meagher & Flom and Simpson, Thacher & Bartlett are helping WeWork go public in one of the most highly anticipated initial public offerings of 2019.
A group of the most prestigious firms in Big Law lined up to advise CBS Corp and Viacom Inc. in their long-awaited all-stock merger that would create a combined company with more than $28 billion in …
Cravath, Swaine & Moore and Wachtell Lipton Rosen & Katz have taken lead roles in Mylan N.V. and Pfizer Inc.’s all-stock tie-up.